Skip to main content



Who Should Get a Second Covid-19 Booster Shot?

Friday, April 1, 2022

The FDA authorized a fourth shot for Americans age 50 and older. Here’s what scientists say you should know.

Illustration of vaccine needlesDr. Topham was quoted in the Wall Street Journal article.

Americans are once again wondering whether they need another Covid-19 shot, with many growing weary of vaccinations.

The U.S. Food and Drug Administration this week authorized a second Covid-19 booster for anyone 50 years and older who had their first booster four or more months ago.

Experts are split on how important it is to get a second booster in light of the low Covid-19 rates in the U.S. and evidence of high protection against death and hospitalization following the first booster. But other countries are experiencing a surge in cases from the Omicron subvariant BA.2, and there are signs that rates are increasing in some parts of the Northeast.

Read More: Who Should Get a Second Covid-19 Booster Shot?

Faculty Highlighted as "Inspiring Women in Science"

Friday, February 11, 2022

Juilee Thakar, PhD, Associate Professor of Microbiology and Immunology, and Paige Lawrence, PhD, Professor and Chair of Environmental Medicine, and Professor of Microbiology and Immunology were both highlighted in URMC's reflection on International Day of Girls and Women in Science. Read more about their stories entering their respective fields and their current work in the article, "Meet Five Inspiring Women in Science".

Edith Lord Recognized by American Association of Immunologists

Thursday, February 3, 2022

The professor of Microbiology & Immunology and Oncology was recently honored with the AAI Distinguished Service Award and named as a Distinguished Fellow of AAI – Class of 2022. Lord, who studies the microenvironment of solid tumors and has an appointment at the Wilmot Cancer Institute, joined AAI in 1978 and served as Secretary-Treasurer from 2015–2021. Both honors pay tribute to her outstanding scientific contributions and her service to AAI and the immunology community.